| Phase 3 | 2 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 3 | ||||
| NCT06150833 | IVIG Boya: Safety, Efficacy, and Pharmacokinetics | Primary Immunodeficiency Disease | Not Yet Recruiting | 2026-06-03 |
| NCT06817096 | Efficacy and Safety of Nitazoxanide 600 Mg in the Outpatient Treatment of COVID-19 and… | Covid 19 | Not Yet Recruiting | 2025-02-10 |